CLINICAL ROLE -
Use of Target-Specific Oral Anticoagulants for Venous Thromboembolism
According to FDA-approved labeling, use of dabigatran and edoxaban for acute VTE treatment requires 5 to 10 days of parenteral anticoagulation.
Chronic Weight Management: New Medications
Two new medications have recently been approved to help patients lose weight: lorcaserin and phentermine and topiramate extended-release.
2 Commerce Drive Cranbury, NJ 08512